Market Value5,164,999,000
Total Holdings95
File Date2022-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ROST / Ross Stores, Inc.
PLAN / Anaplan Inc
PNT / POINT Biopharma Global Inc.
BLSA / BCLS Acquisition Corp - Class A
DICE / DICE Therapeutics Inc
GRAB / Grab Holdings Limited
WRBY / Warby Parker Inc.
VGG3141W1225 / Eucrates Biomedical Acquisition Corp.
KYG9127T1242 / WARRANTS
CANO.WS / Cano Health, Inc. Redeemable Warrants, each whole warrant exercisable for one Class A a
US31809Y1111 / FINSERV ACQUISITION CORP II WT EXPIRATION: 02/03/26
EUROPEAN BIOTECH ACQUTN CORP / *W EXP 03/06/202 (G3167F128)
FRAZIER LIFESCIENCES ACQU CO / *W EXP 11/30/202 (G3710A113)
NRDY / Nerdy, Inc.
PTON / Peloton Interactive, Inc.
VLTA / Volta Inc - Class A
US6710052050 / OPY Acquisition Corp. I
HRTX / Heron Therapeutics, Inc.
ADI / Analog Devices, Inc.
FHTX / Foghorn Therapeutics Inc.
31809Y103 / FinServ Acquisition Corp. II, Class A
EVLV / Evolv Technologies Holdings, Inc.
BCAB / BioAtla, Inc.
ALIT.WS / Alight, Inc. Warrants, each exercisable for one share of Class A at an exercise price o
FRSH / Freshworks Inc.
PRDS / Pardes Biosciences Inc
612657106 / Montes Archimedes Acquisition Corp., Class A
HCAQ / HealthCor Catalio Acquisition Corp - Class A
TWLO / Twilio Inc.
CZOO / Cazoo Group Ltd
NEXI / NexImmune, Inc.
/ Nautilus Biotechnology Inc
OTIC / Otonomy Inc
ABCL / AbCellera Biologics Inc. Call
CMRX / Chimerix, Inc.
ADAG / Adagene Inc. - Depositary Receipt (Common Stock)
CANO / Cano Health, Inc.
SYBX / Synlogic, Inc.
MGTX / MeiraGTx Holdings plc
TRDA / Entrada Therapeutics, Inc.
DECK / Deckers Outdoor Corporation
UNH / UnitedHealth Group Incorporated
DHR / Danaher Corporation
CHRS / Coherus Oncology, Inc.
ALIT / Alight, Inc.
HWM / Howmet Aerospace Inc.
CPRT / Copart, Inc.
CVNA / Carvana Co.
NXPI / NXP Semiconductors N.V.
MRNS / Marinus Pharmaceuticals, Inc.
MOLN / Molecular Partners AG - Depositary Receipt (Common Stock)
INSM / Insmed Incorporated
DCPH / Deciphera Pharmaceuticals, Inc.
KBR / KBR, Inc.
AMZN / Amazon.com, Inc.
ETSY / Etsy, Inc.
TEL / TE Connectivity plc
ORIC / ORIC Pharmaceuticals, Inc.
NUVL / Nuvalent, Inc.
MAR / Marriott International, Inc.
FLAC / Frazier Lifesciences Acquisition Corp - Class A
COR / Cencora, Inc.
PHVS / Pharvaris N.V.
DBTX / Decibel Therapeutics Inc
FULC / Fulcrum Therapeutics, Inc.
ACIU / AC Immune SA
ADBE / Adobe Inc.
SLDB / Solid Biosciences Inc.
FREY / FREYR Battery, Inc.
RXDX / Prometheus Biosciences Inc
ARNA / Arena Pharmaceuticals Inc
IMRX / Immuneering Corporation
TMPM / Turmeric Acquisition Corp - Class A
RACB / Research Alliance Corp II - Class A
RPRX / Royalty Pharma plc
ESTC / Elastic N.V.
BNTC / Benitec Biopharma Inc.
MA / Mastercard Incorporated Call
HLT / Hilton Worldwide Holdings Inc.
ROIV / Roivant Sciences Ltd.
MIST / Milestone Pharmaceuticals Inc.
RARE / Ultragenyx Pharmaceutical Inc.
RIVN / Rivian Automotive, Inc.
OMEG / Omega Alpha SPAC - Class A
INZY / Inozyme Pharma, Inc.
SRNE / Sorrento Therapeutics, Inc.
MA / Mastercard Incorporated
RH / RH
OPEN / Opendoor Technologies Inc.
EBAC / European Biotech Acquisition Corp - Class A
MNST / Monster Beverage Corporation
MQ / Marqeta, Inc.
EUCR / Eucrates Biomedical Acquisition Corp
AMAM / Ambrx Biopharma Inc.
GMTX / Gemini Therapeutics Inc
ACHR / Archer Aviation Inc.
MRTX / Mirati Therapeutics, Inc.
XENE / Xenon Pharmaceuticals Inc.
KZR / Kezar Life Sciences, Inc.
ALLO / Allogene Therapeutics, Inc.
TPR / Tapestry, Inc.
UNP / Union Pacific Corporation
PWR / Quanta Services, Inc.
AGLE / Aeglea BioTherapeutics Inc
SQ / Block, Inc.
GFL / GFL Environmental Inc.
KALV / KalVista Pharmaceuticals, Inc.
EYPT / EyePoint Pharmaceuticals, Inc.
ITCI / Intra-Cellular Therapies, Inc.
RKLB / Rocket Lab Corporation
EL / The Estée Lauder Companies Inc.
OTIS / Otis Worldwide Corporation
MDT / Medtronic plc
AGIO / Agios Pharmaceuticals, Inc.
SIOX / Sio Gene Therapies Inc.
BOLT / Bolt Biotherapeutics, Inc.
TERN / Terns Pharmaceuticals, Inc.
MSFT / Microsoft Corporation
KDNY / Chinook Therapeutics Inc
KURA / Kura Oncology, Inc.
STRO / Sutro Biopharma, Inc.
NTRA / Natera, Inc.
TMO / Thermo Fisher Scientific Inc.
IQV / IQVIA Holdings Inc.
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
IFRX / InflaRx N.V.